Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

4534 - Can Measuring Quality Lead to Improvement? Evidence from International Participants of ASCO’s Quality Oncology Practice Initiative (QOPI®) During 2015-2018

Date

22 Oct 2018

Session

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

Presenters

Mohammad Jahanzeb

Citation

Annals of Oncology (2018) 29 (suppl_8): viii562-viii575. 10.1093/annonc/mdy297

Authors

M. Jahanzeb1, T. Gilmore2, A. Roach2, S.S. Grubbs2, D. Blayney3, J. Hamm4, A. Kamal5, R.J. Kelly6, E. Martin7, J.A. Sanchez8, R. Siegel9, S.T..S. Crist2, J. Rosenthal2, C. Hendricks10

Author affiliations

  • 1 Hem/onc, University of Miami, Sylvester Comprehensive Cancer Center, FL 33442 - Deerfield Beach/US
  • 2 Clinical Affairs, American Society of Clinical Oncology, 22314 - Alexandria/US
  • 3 Medical Oncology, Stanford Comprehensive Cancer Institute, CA 94305-545 - Stanford/US
  • 4 Oncology, Norton Health Care Medical Oncology & Hematology, 40202 - Louisville/US
  • 5 Oncology, Duke University School of Medicine, 27710 - Durham/US
  • 6 Medical Oncology/uad Program, School Of Medicine, Johns Hopkins University, 21231 - Baltimore/US
  • 7 Oncology, Medical Oncology Hematology Consultants, 19713-7000 - Newark/US
  • 8 Oncology, Hospital Escuela, University of Honduras, 11101 - Tegucigalpa/HN
  • 9 Oncology, St. Francis Hospital, 29601 - Greenville/US
  • 10 Oncology, Associates In Oncology Hematology, 20817 - Bethesda/US
More

Resources

Abstract 4534

Background

Management thinker Peter Drucker had famously said “If you can’t measure it, you can’t improve it.” Similar sentiment among practicing oncologists led to the establishment of QOPI by ASCO in 2006. The availability of guidelines to construct measures should result in measurable and sustained improvement in cancer care. QOPI was launched internationally in 2015. Now several countries are participating and 3 (Brazil, Greece and Spain) have QOPI-Certified practices. For the current analysis, we initiated the proof of concept and hypothesized that measuring quality would not only confirm preconceived benchmarks, but lead to improvement.

Methods

Data for analysis was selected from countries’ practices that repeat self-examination. We determined the 5 lowest performing measures excluding the two measures that were deemed not applicable in the Fall (F) and Spring (S) rounds of the years 2015-17. Measure 6 - Pain addressed appropriately (defect-free measures 3, 4a, and 5), Measure 9 - Documented plan for Chemotherapy, including doses, route, and time intervals, Measure 24 - Patient emotional well-being assessed by the second office visit, Measure 33 - Infertility risks discussed prior to chemotherapy with patients of reproductive age and Measure 81-Adjuvant cisplatin-based chemotherapy received within 60 days after curative resection by patients with AJCC Stage II or IIIA NSCLC.

Results

Table: 1587P

RoundMeasure 6Measure 9Measure 24Measure 33Measure 81
Aggregate Mean %
F1575.259.549.210.0N/A
S1658.267.127.316.666.6
F1670.369.440.444.169.3
S1774.380.343.427.950.0
F1783.082.853.838.780.9

This analysis includes 331 physicians and 22 practices from 5 countries (Brazil, Greece, Romania, Saudi Arabia, and Spain) who participated in QOPI rounds between 2015 and 2017. While the scores fluctuated between rounds, first to last observation invariably showed improvement in mean scores.

Conclusions

Measuring quality led to improvement in the lowest performing quality measures in these participating practices. This bodes well for our patients.

Clinical trial identification

Legal entity responsible for the study

American Society of Clinical Oncology.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.